Objective-To evaluate the role of leucocytes in free radical production in patients with depressed or normal ejection fraction undergoing coronary bypass. Design-Two randomised control trials. Setting-Tertiary care centre. Patients and interventions-In the first study, 22 patients with ejection fractions of < 40% received blood cardioplegic reperfusion with (n = 11) or without (n = 11) leucocyte depletion. In the second study, 22 patients with ejection fractions > 45% received either leucocyte depleted (n = 11) or blood cardioplegia (n = 11). Main outcome measures-Glutathione, hypoxanthine, and lipid peroxidation products were measured in coronary sinus blood and plasma before aortic cross clamping and at 0, 15, and 30 minutes after unclamping. Haemodynamic variables and creatine kinase MB isoenzymes were monitored on the first postoperative day. Comparison between treatments was performed on difference (A) between measurements at time 0 and at baseline, and on slopes obtained by fitting measurements after unclamping with a linear regression model. Results-At unclamping no difference in A for plasma glutathione redox ratio (oxidised/total glutathione, %) was observed between treated and control groups with low ejection fraction (A = 16 (SD 8.39) and 24 (7.0) redox ratio %, respectively).
In the past 10 years, a great deal of interest has been focused on the role of leucocytes in generating reperfusion injury in the myocardium.' Activated leucocytes accumulate in reperfused myocardium and are believed to be responsible for capillary plugging, release of arachidonic acid metabolites, activation of complement, and production of oxygen free radicals by the NADPH (reduced nicotinamide adenine dinucleotide phosphate) oxidase pathway.2A Leucocyte depletion induced by pharmacological agents, antineutrophil antibodies, and leucocyte filters has been shown to be protective in animal models.2 4 However, there is little information about the influence of leucocyte depletion of cardioplegic reperfusate on myocardial metabolism and free radical activity during cardiac surgery in humans.
Reactive oxygen species are produced physiologically in cells during redox reactions, including respiration, but their production may be increased in pathological conditions.6 Oxygen free radicals can be cytotoxic by attacking unsaturated fatty acids, starting lipid peroxidation of membranes, and promoting oxidation of protein sulphydryl groups and polypeptide chain scission. Excessive production of free radicals beyond the antioxidant capacity triggers an oxidant stress to the cell. Glutathione, one of the most abundant intracellular antioxidants, acts as cosubstrate for glutathione peroxidase, or as free radical species and lipid peroxide scavenger, with oxidation to the disulphide form. Furthermore, the increase in oxidised glutathione and the inability of the cells to produce reducing equivalents impairs the enzymatic system (glutathione reductase) required for the reduction to reduced glutathione (GSH) , thereby enhancing the loss of GSH. Thus the ratio of the oxidised form to total glutathione (redox ratio) plays an important role in the regulation of the redox state of the cells.8 Oxidised glutathione is actively transported across the cell membrane to plasma and, together with the redox ratio, may be considered a reliable index of oxidative stress.9 10 A well known result of free radical action is peroxidation of membrane polyunsaturated fatty acids, which ultimately results in the production of toxic aldehydes such as malondialdehyde and 4- hydroxynonenal. These can react with critical targets, including proteins, forming fluorescent Schiff bases that are easily detectable.6 " Although lipid peroxidation and antioxidants are non-specific indices of ischaemia-reperfusion injury and can be altered by different processes (such as inflammation), enhanced lipid peroxidation products together with depression of antioxidants is widely accepted as a reliable index of oxygen free radical activity 9 10 12 The aim of our study was to test the hypothesis that leucocyte depletion could improve myocardial protection during revascularisation in patients with a low and preserved ejection fraction undergoing cardiopulmonary bypass. To do this we evaluated changes in glutathione status, fluorescent products of lipid peroxidation, and hypoxanthine in coronary plasma. Because erythrocytes are a natural reserve of antioxidants, determinations were also carried out on whole blood samples.
Methods

PATIENTS
The research was structured in two independent studies on patients undergoing elective myocardial revascularisation. In the first study 22 patients with an ejection fraction < 40% (assessed by a first pass radionuclide angiography) were randomly assigned to receive either blood cardioplegia with leucocyte depletion of cardioplegic reperfusate (LD, n = 11) or blood cardioplegia (LC, control group, n = 11). In the second study 22 subjects with an ejection fraction >o 45% were randomly allocated into two groups: 11 patients received leucocyte depleted blood cardioplegia (ND); and 11 patients were treated with blood cardioplegia (NC, control group). Subjects with other associated cardiac disease, acute myocardial infarction, or cardiogenic shock, as well as patients undergoing additional surgical procedures (valve replacement, aneurysmectomy), were not entered into the protocol. On the basis of a positron emission tomography (PET) study, patients without viable myocardium were also excluded. Antianginal medication was continued until the day of surgery. All patients were operated on by the same surgical staff. Preoperative data are presented in the fig 1A) and a similar trend to normalisation during the following 30 minutes (slope = -0 053 (0.1 1) v -0x076 (0 10) imolImin, LD v LC) was shown in the two groups ( fig  2A) . By contrast, leucocyte depletion improved the recovery rate of the redox ratio % to preischaemic levels (slope = -0-912 (0 380) v -0-158 (0 200) %/min, P < 0 005, LD v LC) (fig 2B) , while A at unclamping was similar (A = 16 (8 4)% v 24 (7 0)%, LD v LC, respectively) ( fig 1B) . In patients with a normal ejection fraction, even though the A showed an increment in plasma oxidised glutathione ( fig 1A) , there was no marked alteration in the redox ratio % at unclamping (fig 1B) , the value remaining unchanged over the following 30 minutes (fig 2B) . During the same period oxidised glutathione normalised Time post-CABG (h) trend in patients with low and normal ejection fractions. No differences were observed between treated patients and controls (table) . In the LD group, the cardiac index improved linearly until it reached a value of 3.99 (0 57) 1/min/m2 at 25 hours, the calculated slope of the curve being significantly different from the respective control group (0 04 (0-03) v 0003 (0.002) l/min/m2/h, P < 0'02, LD v LC) (fig 4) . Both treated and control patients with a normal ejection fraction showed a rapid improvement in cardiac index after the operation (slope = 0 03 (0-02) I/min/ m2/h for both ND and NC), with no difference between treatments.
Discussion
Reperfusion of the ischaemic myocardium is clinically encountered in the thrombolytic treatment of myocardial infarction, coronary angioplasty, bypass surgery, and cardiac transplantation. Although beneficial, uncontrolled reperfusion is associated with tissue damage and functional alteration. Rigid control of reperfusion conditions and reperfusate composition has been shown to be essential for salvaging the previously ischaemic myocardium. '8 Oxygen free radicals, produced during cardiopulmonary bypass, are widely implicated as the main agents of ischaemia-reperfusion injury. The increased free radical activity in the myocardium results from a reperfusion induced burst in production. This burst overwhelms the capacity of defence mechanisms, because a depletion of radical scavengers occurs during ischaemia. Leucocytes, particularly neutrophils, are recognised as one of the major extracellular sources of oxidant species, although not the only one.22 2' The initial step in neutrophil accumulation involves interaction between leucocytes and vascular endothelial cells because of their large size, lack of deformability, and the increased expression of neutrophil binding sites.24-26 Once bound, neutrophils may be activated by various pathways, including superoxide production by xanthine oxidase, complement activation, and leukotriene B4 production.27-29 Neutrophil activation results in greatly enhanced oxygen uptake by cells and in the production of reactive oxygen species.'0 These considerations provide a rationale for the use of leucocyte depleted blood cardioplegia during bypass surgery.
Previous work has emphasised the value of leucocyte depletion in the long term isolated heart, such as in transplantation,2"32 but to the best of our knowledge no data are available on the benefits provided over short ischaemic periods in humans. Since patients with left ventricular dysfunction are considered to be at high perioperative risk and require efficient myocardial protection, in the first study we aimed to evaluate the efficacy of leucocyte depletion of cardioplegic reperfusate in this kind of subject. The efficacy of the treatment prompted us to evaluate leucocyte depletion in patients with preserved ejection fraction. Moreover, since during bypass, brief ischaemic periods alternate with short reperfusion, we decided to extend the leucocyte depletion to all phases of cardioplegia.
In patients with low ejection fraction a sustained increment in oxidant species, associated with an increased formation of lipid peroxidation products, suggests the occurrence of oxidative damage. Leucocyte depletion of cardioplegic reperfusion enhanced myocardial protection by promoting a fast recovery of the plasma redox ratio to preischaemic levels and by lowering fluorescent product formation at unclamping. The efficacy of leucocyte depletion was confirmed by the better time response of the cardiac index. We did not find significant differences in inotropic requirements, probably because of the low dose inotropic support routinely used to wean patients from bypass. The study on patients with normal ejection fraction provided evidence of an increase in plasma oxidised glutathione and in fluorescent products of lipid peroxidation. However, these patients were able to balance production of oxidised glutathione, since no appreciable variation in redox ratio was observed over time in blood and plasma. In this class of subjects, leucocyte depletion did not seem able to provide additional benefits to blood cardioplegia, even though the postoperative cardiac index appeared to be improved by the treatment.
The higher values of plasma hypoxanthine when leucocyte depletion was performed (LD and ND groups) may support the protective effect of the treatment, since the role of xanthine oxidase in generating oxygen free radicals in reperfused organs is well known.3"34 The slower hypoxanthine catabolism may be related to the lack of histamine release from leucocytes, which is responsible for xanthine oxidase activation. 35 Our data on plasma glutathione are only apparently at variance with those published by Ferrari and co-workers in 1990,10 since they achieved myocardial protection by using the St Thomas' Hospital cardioplegic solution, while we used blood cardioplegia. Blood cardioplegia has been shown to be superior to crystalloid cardioplegia36 because blood blends antioxidant benefits with its ability to increase oxygen delivery, prevents ischaemic injury, and limits reperfusion damage. In addition and as described by Buckberg,'6 before aortic unclamping we performed a brief period of controlled blood cardioplegic reperfusion, which limits myocardial damage. Curello et al have recently suggested that sequestration of leucocytes by the heart during the early phase of reperfusion is unlikely to be related to the rate of oxygen free radical production, since they were not able to observe local neutrophil activation in patients with a normal ejection fraction. '7 We found that in patients with low ejection fraction leucocyte depletion of cardioplegic reperfusate improves recovery to preischaemic glutathione redox status in the early phase of reperfusion and improves the mechanical function of the heart in the 24 hours following bypass. These results suggest that leucocytes play a major role in oxidative stress, although activation of the leucocytes is probably not the initiating event.
Although the aim of our study was to assess the efficacy of leucocyte depletion, from our data the response to the ischaemic insult seems to be linked to the baseline ejection fraction. It may be supposed that hearts with left ventricular dysfunction are more susceptible to free radical oxidative damage than normal hearts. However, we cannot rule out the possibility that the lack of benefit observed in patients with a good ejection fraction may be related to a less sustained generation of oxidants than in patients with a poor ejection fraction. To gain a better understanding of the relation between intracellular oxidative processes during bypass surgery and heart function, determination of antioxidants in myocardial biopsies is now in progress.
In conclusion, leucocyte depletion may be advisable in patients with poor heart function, while it appears to provide no benefit in patients with a normal ejection fraction over the routinely used blood cardioplegia.
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